CANCER TREATMENT USING ANTIBODIES THAT BIND CYTOTOXIC T-LYMPHOCYTE ANTIGEN-4 (CTLA-4)

• 收藏
• 分享

专利权人:

REMD Biotherapeutics; Inc.

发明人:

Frank J Calzone,Hai Yan

申请号：

US16487330

公开号：

US20200055937A1

申请日:

2018.01.05

申请国别(地区):

US

年份:

2020

代理人:

摘要：

This application provides, inter alia, antibodies or antigen-binding fragments thereof, targeting CTLA-4 expressed on injured tissues associated with multiple diseases. These anti-CTLA-4 antibodies, or antigen-binding fragments thereof, have a high affinity for CTLA-4 and function to inhibit CTLA-4. The antibodies and antigen-binding fragments are useful for treatment of human diseases, infections, and other conditions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/